#ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. https://t.co/gw1PzhanJ3 @StJudeResearch @CMullighan https://t.co/yGmXNQtr11
#ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. https://t.co/mUtubyofMO @StJudeResearch @CMullighan https://t.co/tQJ8DhE9zo
#ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. https://t.co/FCqwfMdkUk @StJudeResearch @CMullighan https://t.co/wWJS18PjFU
#ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. https://t.co/uDBGbML74D @StJudeResearch @CMullighan https://t.co/QttUSjQiV4
Tässä jutussa analysoitiin vastikään löydettyjen uusien leukemiatyyppien ennusteellista merkitystä 8/n https://t.co/0DQ8cqnXhJ
RT @BCD_AACR: ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-dir…
ICYMI: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. @StJudeResearch @CMullighan https://t.co/QLT1iAE61z https://t.co/SG9nbBVTUi
Scientific Editor @CMullighan presents latest research on #leukemia genetics at #HMSRC21. Read his recent article on this topic in Blood Cancer Discovery. https://t.co/EaclPDIGHz @StJudeResearch #leusm #genomics #hemepath https://t.co/zUEFqrnAQ5
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy https://t.co/5qIjDop1KI
RT @BCD_AACR: From the July issue: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residu…
From the July issue: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. https://t.co/ZfKsGjX0Uh @StJudeResearch @CMullighan https://t.co/FTv0uSoiQ2
Clinical significance of novel subtypes of #pediatric #ALL: PAX5alt, MEF2D-rearranged, and ETV6–RUNX1-like cases showed tendency for relapse despite good early response. This helps therapy planning in future https://t.co/gv1uxJLBt3
RT @BCD_AACR: Related article: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual d…
Related article: Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. @StJudeResearch @CMullighan https://t.co/Fq8XTShBic
Here are some recent free full text articles on the topic in @BCD_AACR : https://t.co/cepKhsmWUD authored by @CMullighan lab: https://t.co/NdSMuj5C7M https://t.co/TDLl2ymCz3 Leukemia collection: https://t.co/pWUWekGiaF #leusm #hemonc
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
RT @StJudeResearch: Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. A…
Online now: Comprehensive genomic subtyping improves prediction of outcome of childhood acute lymphoblastic leukemia. Available @BCD_AACR or #AACR21 poster session. @CMullighan https://t.co/m8mY0stDIu https://t.co/M5MI6oaXKc
@BCD_AACR simultaneous publication with Sima Jeha's #AACR21 presentation CT146: Clinical significance of novel #Leukemia subtypes and MRD in childhood ALL https://t.co/aFoIfmkt2F https://t.co/6uEfySYW9e